Imad Ajjawi
Corporate Officer/Principal bij ABSCI CORPORATION
Actieve functies van Imad Ajjawi
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ABSCI CORPORATION | Corporate Officer/Principal | 01-01-2021 | - |
Denovium, Inc.
 Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Oprichter | - | - |
| Corporate Officer/Principal | 01-08-2018 | - |
Loopbaan van Imad Ajjawi
Opleiding van Imad Ajjawi
| University of California San Diego | Masters Business Admin |
| University of Nevada | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABSCI CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Denovium, Inc.
Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Technology Services |
- Beurs
- Insiders
- Imad Ajjawi
- Ervaring
